Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients

Por Vaishampayan, Ulka, Thakur, Archana, Rathore, Ritesh, Kouttab, Nicola, Lum, Lawrence G.
Publicado no Prostate Cancer (2015)

PedVacc 002: A phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants...

Por Njuguna, Irene N., Ambler, Gwen, Reilly, Marie, Ondondo, Beatrice, Kanyugo, Mercy, Lohman-Payne, Barbara, Gichuhi, Christine, Borthwick, Nicola, Black, Antony, Mehedi, Shams-Rony, Sun, Jiyu, Maleche-Obimbo, Elizabeth, Chohan, Bhavna, John-Stewart, Grace C., Jaoko, Walter, Hanke, Tomáš
Publicado no Vaccine (2014)

Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial

Por Moran, Teresa, Felip, Enriqueta, Keedy, Vicki, Borghaei, Hossein, Shepherd, Frances A, Insa, Amelia, Brown, Holly, Fitzgerald, Timothy, Sathyanarayanan, Sriram, Reilly, John F, Mauro, David, Hsu, Karl, Yan, Li, Johnson, David H
Publicado no Exp Hematol Oncol (2014)

Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis: a Phase 1 randomised controlled trial in sexually active women

Por Keller, Marla J, Wood, Lianna, Billingsley, James M, Ray, Laurie L, Goymer, Jessica, Sinclair, Shada, McGinn, Aileen P, Marzinke, Mark A, Frank, Bruce, Srinivasan, Sujatha, Liu, Congzhou, Atrio, Jessica M, Espinoza, Lilia, Mugo, Nelly, Spiegel, Hans M L, Anderson, Peter L, Fredricks, David N, Hendrix, Craig W, Marrazzo, Jeanne, Bosinger, Steven E, Herold, Betsy C
Publicado no Lancet HIV (2019)

NT-18 PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY

Por Lang, Frederick F., Conrad, Charles, Gomez-Manzano, Cande, Tufaro, Frank, Sawaya, Raymond, Weinberg, Jeffrey, Prabhu, Sujit, Fuller, Gregory, Aldape, Kenneth, Fueyo, Juan
Publicado em 2014

Epitope-specific immunotherapy targeting CD4+ T cells in celiac disease: evaluation in randomized, double-blind, placebo-controlled phase 1 studies

Por Goel, Gautam, King, Tim, Daveson, A James, Andrews, Jane M, Krishnarajah, Janakan, Krause, Richard, Brown, Gregor, Fogel, Ronald, Barish, Charles F, Epstein, Roger, Kinney, Timothy P, Miner, Philip B, Tye-Din, Jason A, Girardin, Adam, Taavela, Juha, Popp, Alina, Sidney, John, Mäki, Markku, Goldstein, Kaela E, Griffin, Patrick H, Wang, Suyue, Dzuris, John L, Williams, Leslie J, Sette, Alessandro, Xavier, Ramnik J, Sollid, Ludvig M, Jabri, Bana, Anderson, Robert P
Publicado no Lancet Gastroenterol Hepatol (2017)

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo...

Por Emery, P, Deodhar, A, Rigby, W F, Isaacs, J D, Combe, B, Racewicz, A J, Latinis, K, Abud-Mendoza, C, Szczepański, L J, Roschmann, R A, Chen, A, Armstrong, G K, Douglass, W, Tyrrell, H
Publicado em 2010

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study

Por Huhn, Gregory D., Eron, Joseph J., Girard, Pierre-Marie, Orkin, Chloe, Molina, Jean-Michel, DeJesus, Edwin, Petrovic, Romana, Luo, Donghan, Van Landuyt, Erika, Lathouwers, Erkki, Nettles, Richard E., Brown, Kimberley, Wong, Eric Y.
Publicado no AIDS Res Ther (2019)

A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy

Por Cho, May, Gong, Jun, Frankel, Paul, Synold, Timothy W., Lim, Dean, Chung, Vincent, Chao, Joseph, Li, Daneng, Chen, Yuan, Sentovich, Stephen, Melstrom, Kurt, Singh, Gagandeep, Luevanos, Eloise, Fakih, Marwan
Publicado no Oncotarget (2017)

A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial

Por Peppe, Jennifer, Porzio, Andrew, Davidson, David M
Publicado em 2008

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

Por Wyles, David, Bräu, Norbert, Kottilil, Shyam, Daar, Eric S, Ruane, Peter, Workowski, Kimberly, Luetkemeyer, Anne, Adeyemi, Oluwatoyin, Kim, Arthur Y, Doehle, Brian, Huang, K C, Mogalian, Erik, Osinusi, Anu, McNally, John, Brainard, Diana M, McHutchison, John G, Naggie, Susanna, Sulkowski, Mark
Publicado no Clin Infect Dis (2017)

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Por Lawitz, Eric, Matusow, Gary, DeJesus, Edwin, Yoshida, Eric M., Felizarta, Franco, Ghalib, Reem, Godofsky, Eliot, Herring, Robert W., Poleynard, Gary, Sheikh, Aasim, Tobias, Hillel, Kugelmas, Marcelo, Kalmeijer, Ronald, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Sinha, Rekha, Witek, James
Publicado no Hepatology (2016)

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Por Hirooka, Yoshiki, Kasuya, Hideki, Ishikawa, Takuya, Kawashima, Hiroki, Ohno, Eizaburo, Villalobos, Itzel B., Naoe, Yoshinori, Ichinose, Toru, Koyama, Nobuto, Tanaka, Maki, Kodera, Yasuhiro, Goto, Hidemi
Publicado no BMC Cancer (2018)

A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)

Por Hamamoto, Yasuo, Yamaguchi, Tatsuro, Nishina, Tomohiro, Yamazaki, Kentaro, Ura, Takashi, Nakajima, Takako, Goto, Ayumu, Shimada, Ken, Nakayama, Norisuke, Sakamoto, Junichi, Morita, Satoshi, Yamada, Yasuhide
Publicado no Oncologist (2014)

RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY

Por P Mehta, Minesh, Gondi, Vinai, Ahluwalia, Manmeet, D Brown, Paul
Publicado no Neuro Oncol (2018)

Development and Experimental Evaluation of Concurrent Control of a Robotic Arm and Continuum Manipulator for Osteolytic Lesion Treatment

Por Wilkening, Paul, Alambeigi, Farshid, Murphy, Ryan J., Taylor, Russell H., Armand, Mehran
Publicado no IEEE Robot Autom Lett (2017)

Performance Analysis of Full Assembly Glass Fiber-Reinforced Polymer Composite Cross-Arm in Transmission Tower

Por Agusril Syamsir, Afiqah Nadhirah, Daud Mohamad, Salmia Beddu, Muhammad Rizal Muhammad Asyraf, Zarina Itam, Vivi Anggraini
Publicado em 2022-04-01

Direct transcatheter aortic valve implantation – one-year outcome of a case control study

Por Kochman, Janusz, Kołtowski, Łukasz, Huczek, Zenon, Scisło, Piotr, Bakoń, Leopold, Wilimski, Radosław, Rymuza, Bartosz, Opolski, Grzegorz
Publicado no Postepy Kardiol Interwencyjnej (2014)

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Por Wang, Jianxiang, Shen, Zhi-Xiang, Saglio, Giuseppe, Jin, Jie, Huang, He, Hu, Yu, Du, Xin, Li, Jianyong, Meng, Fanyi, Zhu, Huanling, Hu, Jianda, Wang, Jianmin, Hou, Ming, Hertle, Sabine, Menssen, Hans D., Ortmann, Christine-Elke, Tribouley, Catherine, Yuan, Ye, Baccarani, Michele, Huang, Xiaojun
Publicado no Blood (2015)

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined...

Por Podrazil, Michal, Horvath, Rudolf, Becht, Etienne, Rozkova, Daniela, Bilkova, Pavla, Sochorova, Klara, Hromadkova, Hana, Kayserova, Jana, Vavrova, Katerina, Lastovicka, Jan, Vrabcova, Petra, Kubackova, Katerina, Gasova, Zdenka, Jarolim, Ladislav, Babjuk, Marek, Spisek, Radek, Bartunkova, Jirina, Fucikova, Jitka
Publicado no Oncotarget (2015)